Micro Emerging Active

AZN receives EU approval for Imfinzi in early gastric/gastroesophageal cancers

Score
0.3
Velocity
▲ 0.0
Articles
3
Sources
3

Summary

An article belongs to this narrative if it discusses AstraZeneca's EU approval for Imfinzi in early gastric/gastroesophageal cancers.

Related Articles

AstraZeneca (AZN) Announces EU Approval of Imfinzi for Early Gastric/Gastroesophageal Cancers

Yahoo Finance · Mar 25, 2026
Mixed

Sources

AstraZeneca stock jumps 4% after surprise trial win for lung … CNBC
Agilent Announces Expanded Approval Of PD-L1 IHC 22C3 PharmDx In … Nasdaq
AstraZeneca (AZN) Announces EU Approval of Imfinzi for Early Gastric/Gastroesophageal … Yahoo Finance

Timeline

Last Updated Mar 25, 2026